Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Preventive Maintenance and Repair Service Agreement for Emulate Zoe CM1 and CM2 culture modules

Closed
CDER-2026-132585Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 811210
New
SLED
Statewide Standby Generator, ATS & UPS Preventive Maintenance Services
Solicitation # BD-27-1107-FREG5-ACCOU-133129
The Massachusetts Trial Court, through the Office of Court Management, Facilities Management & Capital Planning, is soliciting bids for statewide preventive maintenance, inspection, operational testing, load-bank testing, repair, and emergency services for standby generators, automatic transfer switches, and uninterruptible power supply systems. The contract is structured into five independent regional award groups, with each region being awarded to the lowest responsible and eligible bidder. The initial performance period is 32 months, running from November 1, 2026, to June 30, 2029, with two optional one-year renewals available through June 30, 2031. Bidders must submit their response packages electronically via the COMMBUYS portal by September 30, 2026, including a bid deposit of at least 5 percent of the greatest possible bid amount per region. Award evaluation is based on bid responsiveness, eligibility, and the lowest evaluated regional price, with a requirement that contractors demonstrate the capacity to perform in multiple regions simultaneously if awarded more than one. Contractors must adhere to NFPA 70B, the Massachusetts Comprehensive Fire Safety Code, and the Massachusetts Electrical Code, and are required to provide detailed electronic service reports as a condition of payment. Payments are processed via Electronic Funds Transfer through the Comptroller's system, typically 45 days from invoice receipt.
FREG5 - Facilities Management & Capital Planning - Region V

POSTED

about 22 hours ago

DEADLINE

in 18 days

AI Contract Overview

Show more

The U.S. Food and Drug Administration is conducting market research to identify qualified small business and other capable providers for a one-year preventive and corrective maintenance agreement for Emulate Zoe CM1 and CM2 culture modules and associated equipment used in advanced microphysiological system research. The goal is to ensure uninterrupted operational functionality of the instruments used to study bronchopulmonary drug disposition and drug transfer into milk, supporting regulatory science initiatives under the Center for Drug Evaluation and Research. The maintenance contract requires one annual on-site preventive maintenance visit per instrument, with all labor, parts, travel, and consumables included, as well as unlimited on-site corrective repairs if remote troubleshooting fails after two business days. All service must be performed by Emulate Inc.-certified engineers using only OEM-certified components, following official manuals and service bulletins, with full coverage for software and firmware updates, and 24/5 technical support via phone and email. The agreement must also cover ten Chip-S1 and seven Chip-R1 Basic Research Kits, Steriflip filters, ER-1/ER-2 activation systems, and compound distribution kits used in drug absorption studies, ensuring proper calibration and fluidic flow control. The equipment is located at the FDA White Oak Campus in Silver Spring, Maryland, and the contract period runs from July 15, 2026, to July 14, 2027, with all service activities required to avoid federal holidays. The contractor must provide detailed service reports after each visit and coordinate all maintenance schedules directly with the designated FDA project lead prior to any work. Responses must include comprehensive evidence of capability: technical documentation, ISO certifications, three years of relevant past performance with full client details, estimated response times, available service plans, and information on compliance with Section 508 accessibility standards. Bidders must disclose if specifications are overly restrictive and, if a large business, outline subcontracting opportunities for small businesses. Pricing information, business size status, SAM registration, place of manufacture, and warranty terms are required, and responses must avoid web links or unsubstantiated claims. This is not a solicitation or procurement but a market research effort to inform future contracting decisions, with submissions due by May 26, 2026, to a designated FDA point of contact.

General Info

FDA seeks one-year maintenance and repair service for Emulate Zoe culture modules from small businesses.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

811210 - Electronic and Precision Equipment Repair and MaintenanceView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA

Full Description

Show more

MARKET RESEARCH PURPOSES ONLY


NOT A REQUEST FOR PROPOSAL OR SOLICITATION


The U.S. Food and Drug Administration (FDA) is conducting market research to support the Center for Drug Evaluation and Research (CDER), requirement for Preventive Maintenance and Repair Service Agreement for Emulate Zoe CM1 and CM2 culture modules.   


The FDA is seeking small business sources to determine the availability and capability of small businesses capable of providing the required supplies. Other than small business concerns are also encouraged to submit capability statements. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for this effort.


The associated North American Industry Classification System (NAICS) Code is- 811210 - Electronic and Precision Equipment Repair and Maintenance; the applicable Small Business Size Standard is $34 million.


Statement of Work


Background


The Division of Applied Regulatory Science (DARS) in OCP/OTS/CDER is conducting a research program to evaluate the utility of a microphysiological system (MPS) in assessing the bronchopulmonary disposition of anti-infective drugs and predicting drug transfer into milk. MPS barrier models, such as lung alveolar and blood-milk barriers, provide a physiologically relevant in vitro platform that integrates key components—epithelial and endothelial cells, along with dynamic fluid flow—to better mimic the cellular microenvironment compared to traditional in vitro models. This research aims to assess the concordance between drug concentration profiles obtained from MPS experiments and clinical studies, offering alternative or complementary approaches to clinical research. Evaluating the lung alveolar model may provide critical insights into drug penetration into alveolar epithelial lining fluid (ELF) and support regulatory decision-making in drug development. Similarly, assessing the blood-milk barrier model will determine its predictive accuracy by comparing outputs with available clinical data, including the InfantRisk Human Milk Biorepository (HMB), as well as nonclinical data from various studies. The findings from this study may contribute to the broader regulatory science framework by informing model validation, study design, and the integration of advanced in vitro models into nonclinical and clinical development programs. To ensure the continued success of this research program, proper maintenance of the Emulate machinery is essential to maintain data quality, equipment reliability, and operational continuity.


Objectives


The objective of the contract is to obtain a one-year maintenance contract including one-time preventative maintenance service and one year of coverage for Emulate machinery, specifically the Zoe CM1 and CM2 culture modules and related equipment, manufactured -by Emulate, Inc. (Boston, USA). This maintenance will provide the FDA with the necessary technology and resources to support research on MPS barrier models. The system will be used to advance scientific capabilities in evaluating bronchopulmonary drug disposition and predicting drug transfer into milk, consistent with the mission of the Center for Drug Evaluation and Research (CDER). The acquired maintenance for machinery and kits will facilitate studies aimed at assessing the utility of MPS barrier models as alternative or complementary approaches to clinical research, contributing to regulatory science and drug development.


Scope


FDA is seeking maintenance for our existing Emulate machinery, the Zoe CM modules and related equipment. Preventative maintenance, corrective/remedial maintenance repair service agreement on CM1 serial numbers: ZOE-CM1 00142 ZOE-CM1-00141 and CM2, serial numbers: ZOE-CM2-00237 ZOE-CM2 00235


Performance Requirements


-The contractor shall provide one (1) scheduled on-site planned preventive maintenance visit per year per instrument. The consumables required for PM visit shall be included in the contract. All costs for labor, travel, and parts required for preventative maintenance shall be included.


-The contractor shall provide unlimited on-site corrective maintenance and repairs where problems cannot be resolved remotely after 2 business days. All costs for labor, travel, and parts shall be included.


-The maintenance and repair activities shall be performed by the service engineers who are trained and certified by the manufacturer Emulate Inc., and the service provider should follow the Original Equipment Manufacturer (OEM) specifications, manuals, and service bulletins, using OEM-certified replacement parts, components, subassemblies, etc.


-The contractor shall include unlimited software and firmware updates during the entire coverage period(s).


-The contractor shall include unlimited technical support (via phone and email) on software and hardware related issues and trouble-shooting capabilities, Monday through Friday (excluding Federal Holidays).


- Access by the FDA COR and system operator personnel to the manufacturer’s call center for technical assistance including software, which is staffed by senior engineers to provide a high level of expertise for troubleshooting the instrument. 


-All maintenance and repair pricing must encompass costs for labor, travel, replacement parts, components, subassemblies, and any other necessary expenses related to the system.


- Deliverables: Service Records and Reports: Contractor shall provide a service record report in contractor’s standard format after each PM or repair visit.


-Maintenance services must ensure proper functioning of equipment compatible with lung and blood-milk barriers' MPS chips for Emulate's Zoe Culture Module to enable continuous fluidic flow control.


- Maintenance coverage must include all compatible MPS chips and equipment, including: a. Ten Chip-S1 Basic Research Kits (BRK-S1-WER-24) with the Chip-S1 Stretchable Chip and accompanying Pod Portable Module. b. Seven Chip-R1 Basic Research Kits (BRK-R1-WER-24) with the Chip-R1 Non-Stretchable Chip and accompanying Pod Portable Module.


- Maintenance services must ensure proper calibration and functionality of all equipment components, including Steriflip filters and ER-1/ER-2 Chip Activation Reagent systems.


- Contractor shall provide updated technical documentation and step-by-step instructions for the use of Emulate consumable chips as part of maintenance services.


- Maintenance coverage must include equipment used with compound distribution kits for drug absorption studies.


- Contractor shall complete functional QC testing of all equipment during preventative maintenance service to ensure optimal performance and reliability.


The Contractor shall guarantee that all required maintenance services shall be performed to ensure equipment remains in optimal, usable and acceptable condition at the address as shown below.


- Vendor must notify recipient via email with service scheduling information when maintenance is planned.


Other


Government Points of Contact:


Attn: to be identified at time of award


Vendor will contact the Project Lead: to be identified at time of award by phone or email to schedule maintenance service.


Maintenance services must be coordinated with the Project Lead prior to scheduling. No services will be performed without prior authorization from the Project Lead.


Vendor must notify recipient via email with service scheduling information when maintenance is planned.


Government Furnished Equipment (GFE)/ Government       Furnished Information (GFI)


  • NA

Place of Performance


FDA White Oak Campus


US Food and Drug Administration


10903 New Hampshire Ave, WO 64 Rm 2083


Silver Spring, MD 20993


Period of Performance


Period of Performance will be for One (1) year from date of award, beginning July 15 2026 and ending July 14 2027.


Inspection and Acceptance Criteria


The Government will review all reporting requirement deliverables in accordance with specifications and standards identified in the statement of work or any directives issued by the COR. The contractor shall submit the reporting Requirements/Deliverables to the COR in accordance with the delivery schedule. The COR will perform inspection and acceptance of materials and services.


FOB Point Destination. All items shall include shipping and handling to the destination identified herein.


Holidays and Government Closures


Service/Delivery shall not be scheduled during Federal Holidays or Federal Closures as determined by Executive Orders or opm.gov. Federal Holidays are as follows:


New Year’s Day                                       Labor Day


Martin Luther King, Jr.’s Birthday           Columbus Day


Washington’s Birthday                             Veterans Day


Memorial Day                                           Thanksgiving Day


Juneteenth Day                                        Christmas Day


Independence Day           


Contract Type: Firm Fixed Price


Alternative solutions will be considered insofar as any such alternate system and/or system components meet the minimum intended use of the system and brand name or equal technical requirements.


The offeror shall furnish sufficient technical information necessary for the Government to conclusively determine that the offered products/services and components meet the technical requirements identified above. Though the target audience is small business manufacturers or small businesses capable of supplying a U.S. made product/service of a small business manufacturer or producer all interested parties may respond.  At a minimum, responses shall include the following:


  • Business name, SAM Unique Entity ID number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address (Provide this same information if responding to provide a product manufactured by another firm);
  • Sufficient descriptive literature that unequivocally demonstrates that offered products and services can meet the above requirements. All descriptive material necessary for the government to determine whether the service/product offered meets the technical requirements including: technical specifications, ISO certifications, descriptive material, literature, brochures and other information, which demonstrates the capabilities of the contractor to meet the requirement.
  • Three (3) years of past performance information, where the respondent has provided same or substantially similar product/service solutions on the same or near-same requirements. For each past performance reference include the date of sale, description, dollar value, client name, client address, client point of contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include SAM Unique Entity ID number and size status) if not the respondent.
  • The offeror’s capability to initiate service on-site within the time specified above.
  • Offeror shall provide estimated historical on-site response time from the initial call for service until a service technician was on-site for the brand name and model of instrument in this solicitation or a standard target time for onsite performance from initiation of service call.
  • Service/repair agreement plans that are available for the Make/Model of the system described above.
  • If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this potential requirement. Detailed list of items included and not included on the GSA contract to meet this requirement.
  • If applicable, identification of Best in Class (BIC) contract information or other Government-wide or HHS-wide contracts that the equipment/service is available on.
  • Identification of AbilityOne Contracts available that can meet the requirement.
  • Capability and understanding of accessibility testing and customization to conform with the applicable Section 508 standards identified herein. Provide information if the respondent has an Accessibility Conformance Report (ACR) for the products offered for the Revised 508 Standards. The ACR should be based on the Voluntary Product Accessibility Template Version 2.0  (MS Word) provided by the Industry Technology Industry Council (ITIC).
  • Provide information if any of these specifications are too restrictive. Failure to provide information indicating that the listed specifications are too restrictive will be interpreted as confirmation that the specifications are adequate for a competitive environment.
  • If a large business, identify the subcontracting opportunities that would exist for small business concerns;
  • Standard commercial warranty and payment terms;
  • Provide place of product manufacture or service performance and any other applicable information to enable review and analysis pertaining to the Buy American statute and requirements relating to Made in America in the event a nonavailability waiver request through the MIAO Digital Waiver Portal is needed; and
  • Though this is not a request for quote, informational pricing is required

The government is not responsible for locating or securing any information, not identified in the response.


The Government encourages any comments and/or suggestions from any interested party, regarding the specifications. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation.


Interested Parties shall respond with capability statements which are due by email to the point of contact listed below on or before May 26, 2026 by 13:00 hours (Central Time in Jefferson, Arkansas) to nick.sartain@fda.hhs.gov. Reference CDER-2026-132585.


Notice of Intent


Responses to this sources sought announcement will assist the Government in determining whether or not any future requirement similar to this one should be set aside for small business, made available to full and open competition or procure through sole-source acquisition procedures.


Disclaimer and Important Notes


This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work.


Responses with weblinks will not be opened or viewed.


Responses must demonstrate capability, not merely affirm the respondent's capability (i.e. the response must go beyond the statement that, "XYZ company can provide the instrument, technical support etc.").


Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in sam.gov. However, responses to this notice will not be considered adequate responses to a solicitation.


Confidentiality


No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS